Elmer Maurits

Proteasome Inhibition in Multiple Myeloma: Head-to-Head Comparison of Currently Available Proteasome Inhibitors

Andrej Bešše, Lenka Bešše, Marianne Kraus et al. · Cell chemical biology · 2019 · 112 citations · Full text

Hematological Malignancy, Proteasome Inhibition, Oncology +11

Co‐inhibition of immunoproteasome subunits LMP2 and LMP7 is required to block autoimmunity

Michael Basler, Michelle Lindström, Jacob LaStant et al. · EMBO Reports · 2018 · 70 citations · Full text

Molecular Immunology, Autoimmune Disease, Autoantibody Production +11

Chemical Control over T-Cell Activation <i>in Vivo</i> Using Deprotection of <i>trans</i>-Cyclooctene-Modified Epitopes

Anouk M. F. van der Gracht, Mark A. R. de Geus, Marcel Camps et al. · ACS Chemical Biology · 2018 · 47 citations · Full text

Fast and pH‐Independent Elimination of <i>trans</i>‐Cyclooctene by Using Aminoethyl‐Functionalized Tetrazines

Alexi J. C. Sarris, Thomas Hansen, Mark A. R. de Geus et al. · Chemistry - A European Journal · 2018 · 42 citations · Full text

Chemical Engineering, Bioorganic Chemistry, Engineering +12

Amelioration of autoimmunity with an inhibitor selectively targeting all active centres of the immunoproteasome

Michael Basler, Elmer Maurits, Gerjan de Bruin et al. · British Journal of Pharmacology · 2017 · 37 citations · Full text